BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37712963)

  • 1. CPVL suppresses metastasis of nasopharyngeal carcinoma through inhibiting epithelial-mesenchymal transition.
    Wang X; Chen L; Huang K; Lin Y; Hong Y; Lin Z
    J Cancer Res Clin Oncol; 2023 Dec; 149(18):16473-16488. PubMed ID: 37712963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-296-5p inhibits cell metastasis and invasion in nasopharyngeal carcinoma by reversing transforming growth factor-β-induced epithelial-mesenchymal transition.
    Chen M; Chen C; Luo H; Ren J; Dai Q; Hu W; Zhou K; Tang X; Li X
    Cell Mol Biol Lett; 2020 Nov; 25(1):49. PubMed ID: 33292168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High SRC-1 and Twist1 expression predicts poor prognosis and promotes migration and invasion by inducing epithelial-mesenchymal transition in human nasopharyngeal carcinoma.
    Zhou J; Zhang J; Xu M; Ke Z; Zhang W; Mai J
    PLoS One; 2019; 14(4):e0215299. PubMed ID: 30973923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADAM22 acts as a novel predictive biomarker for unfavorable prognosis and facilitates metastasis via PI3K/AKT signaling pathway in nasopharyngeal carcinoma.
    Xu K; Jiang P; Chen Z; Gu X; Zhang T
    Pathol Res Pract; 2024 Apr; 256():155264. PubMed ID: 38518731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGF2BP3 promotes cell metastasis and is associated with poor patient survival in nasopharyngeal carcinoma.
    Xu Y; Guo Z; Peng H; Guo L; Wang P
    J Cell Mol Med; 2022 Jan; 26(2):410-421. PubMed ID: 34894048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OVOL2 links stemness and metastasis via fine-tuning epithelial-mesenchymal transition in nasopharyngeal carcinoma.
    Qi XK; Han HQ; Zhang HJ; Xu M; Li L; Chen L; Xiang T; Feng QS; Kang T; Qian CN; Cai MY; Tao Q; Zeng YX; Feng L
    Theranostics; 2018; 8(8):2202-2216. PubMed ID: 29721073
    [No Abstract]   [Full Text] [Related]  

  • 7. YPEL3 suppresses epithelial-mesenchymal transition and metastasis of nasopharyngeal carcinoma cells through the Wnt/β-catenin signaling pathway.
    Zhang J; Wen X; Ren XY; Li YQ; Tang XR; Wang YQ; He QM; Yang XJ; Sun Y; Liu N; Ma J
    J Exp Clin Cancer Res; 2016 Jul; 35(1):109. PubMed ID: 27400785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by down-regulating LHX2.
    Liang TS; Zheng YJ; Wang J; Zhao JY; Yang DK; Liu ZS
    J Exp Clin Cancer Res; 2019 Feb; 38(1):97. PubMed ID: 30791932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-184 Inhibits Tumor Invasion, Migration and Metastasis in Nasopharyngeal Carcinoma by Targeting Notch2.
    Zhu HM; Jiang XS; Li HZ; Qian LX; Du MY; Lu ZW; Wu J; Tian XK; Fei Q; He X; Yin L
    Cell Physiol Biochem; 2018; 49(4):1564-1576. PubMed ID: 30223264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA UCA1 affects epithelial-mesenchymal transition, invasion, migration and apoptosis of nasopharyngeal carcinoma cells.
    Han R; Chen S; Wang J; Zhao Y; Li G
    Cell Cycle; 2019 Nov; 18(21):3044-3053. PubMed ID: 31537148
    [No Abstract]   [Full Text] [Related]  

  • 11. hsa‑miR‑24 suppresses metastasis in nasopharyngeal carcinoma by regulating the c‑Myc/epithelial‑mesenchymal transition axis.
    Su B; Xu T; Bruce JP; Yip KW; Zhang N; Huang Z; Zhang G; Liu FF; Liang J; Yang H; Claret FX
    Oncol Rep; 2018 Nov; 40(5):2536-2546. PubMed ID: 30226609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling.
    Liu Y; Liu Q; Chen S; Liu Y; Huang Y; Chen P; Li X; Gao G; Xu K; Fan S; Zeng Z; Xiong W; Tan M; Li G; Zhang W
    FASEB J; 2019 Nov; 33(11):11959-11972. PubMed ID: 31408612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of long non-coding RNA TUG1 suppresses nasopharyngeal carcinoma progression by inhibiting epithelial-mesenchymal transition (EMT) via the promotion of miR-384.
    Qian W; Ren Z; Lu X
    Biochem Biophys Res Commun; 2019 Jan; 509(1):56-63. PubMed ID: 30581000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blocking PI3K/Akt signaling attenuates metastasis of nasopharyngeal carcinoma cells through induction of mesenchymal-epithelial reverting transition.
    Jiang H; Gao M; Shen Z; Luo B; Li R; Jiang X; Ding R; Ha Y; Wang Z; Jie W
    Oncol Rep; 2014 Aug; 32(2):559-66. PubMed ID: 24889918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of cytoskeleton-associated protein 4 is associated with poor prognosis and metastasis in nasopharyngeal carcinoma.
    Cai M; Wu W; Deng S; Yang Q; Wu H; Wang H; Zhang J; Feng Q; Shao J; Zeng Y; Li J
    Exp Biol Med (Maywood); 2023 Jun; 248(12):1085-1094. PubMed ID: 37208923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SATB1 Knockdown Inhibits Proliferation and Invasion and Decreases Chemoradiation Resistance in Nasopharyngeal Carcinoma Cells by Reversing EMT and Suppressing MMP-9.
    Zhou D; Ye C; Pan Z; Deng Y
    Int J Med Sci; 2021; 18(1):42-52. PubMed ID: 33390772
    [No Abstract]   [Full Text] [Related]  

  • 17. Let-7a inhibits migration, invasion and epithelial-mesenchymal transition by targeting HMGA2 in nasopharyngeal carcinoma.
    Wu A; Wu K; Li J; Mo Y; Lin Y; Wang Y; Shen X; Li S; Li L; Yang Z
    J Transl Med; 2015 Mar; 13():105. PubMed ID: 25884389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficiency of pigment epithelium-derived factor in nasopharyngeal carcinoma cells triggers the epithelial-mesenchymal transition and metastasis.
    Zhang T; Yin P; Zhang Z; Xu B; Che D; Dai Z; Dong C; Jiang P; Hong H; Yang Z; Zhou T; Shao J; Xu Z; Yang X; Gao G
    Cell Death Dis; 2017 Jun; 8(6):e2838. PubMed ID: 28569772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of lncRNA SNHG12 predicts a poor prognosis of nasopharyngeal carcinoma and regulates cell proliferation and metastasis by modulating Notch signal pathway.
    Liu ZB; Tang C; Jin X; Liu SH; Pi W
    Cancer Biomark; 2018; 23(4):603-613. PubMed ID: 30452404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA EPB41L4A-AS2 represses Nasopharyngeal Carcinoma Metastasis by binding to YBX1 in the Nucleus and Sponging MiR-107 in the Cytoplasm.
    Du M; Hu X; Jiang X; Yin L; Chen J; Wen J; Fan Y; Peng F; Qian L; Wu J; He X
    Int J Biol Sci; 2021; 17(8):1963-1978. PubMed ID: 34131399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.